Navigation Links
Summit VetPharm Offers New Flea Topical Vectra for Dogs & Puppies(TM) For Long-Lasting Protection
Date:4/15/2009

Dinotefuran and Pyriproxyfen Combination Delivers Safe and Effective Control of All Stages of Fleas on Dogs

FORT LEE, N.J., April 15 /PRNewswire/ -- Summit VetPharm announces the introduction of Vectra for Dogs & Puppies(TM), a new monthly, topical, flea control product containing dinotefuran and pyriproxyfen in combination to deliver a complete single dose monthly applied product that protects your dog from all stages of fleas -- adults, eggs, larvae and pupae. Vectra for Dogs & Puppies(TM) is the newest product in the Vectra(R) line from Summit VetPharm which includes Vectra 3D(R), Vectra(R) for Cats & Kittens and Vectra for Cats(R). It can be used on dogs as young as eight weeks of age for year round flea treatment and prevention.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090415/NY99255 )

Vectra for Dogs & Puppies(TM):

  • Kills adult fleas; starts killing fleas within 2 hours
  • Provides ongoing protection against fleas and the diseases they may transmit, including tularemia, bartonellosis and rickettsiosis
  • Protects dogs from flea infestations that may cause anemia, tapeworm disease and flea allergy dermatitis (FAD)
  • Contains an IGR -- pyriproxyfen -- stable in sunlight, prevents development of all immature flea stages (eggs, larvae and pupae) for 1 month
  • Can be used on puppies as young as 8 weeks of age
  • Patented applicator provides convenient topical treatment

Vectra for Dogs & Puppies(TM) efficacy data confirms that it has one of the quickest onsets of killing activity of any topical flea product, while providing month-long protection against all stages of fleas (eggs, larvae, pupae and adult fleas). "In a study conducted to evaluate the duration of adulticide activity against fleas for Vectra(R) in dogs weighing 21-55 pounds, Vectra(R) began killing fleas within 2 hours following a single application and continued to perform for 30 days maintaining a 100% reduction in fleas throughout the duration of the study," explained Dr. Cathy Ball, Summit VetPharm Veterinary Services.

"Pet owners want fleas killed as quickly as possible to end their dog's suffering," says Dr. Ball. "Oftentimes, the successive feeding activity of fleas on dogs elicits a hypersensitivity skin disorder known as flea allergy dermatitis (FAD). Treatment of dogs with Vectra for Dogs & Puppies(TM) kills fleas and may reduce further evidence of FAD."

Pet owners and their dogs have a variety of lifestyles. Differing lifestyles, coupled with the differing parasites endemic to the area of the country, means their vector protection needs may be different. "Vectra for Dogs & Puppies(TM) is the perfect companion to Vectra 3D(R)," says Julia Stephanus, President and CEO of Summit VetPharm. "The Vectra for Dogs and Puppies(TM) is recommended for dogs whose lifestyles, size, breed and geography dictate the need for outstanding flea protection. Vectra 3D(R), our first commercial veterinary product, has a broader spectrum for those dogs whose lifestyle exposes them to fleas, ticks, mosquitoes, lice, mites and sand flies."

Vectra for Dogs & Puppies(TM) dual-action formula includes dinotefuran, a fast-acting, third generation neonicotinoid with a novel mode of action and pyriproxyfen, an insect growth regulator (IGR) that controls and prevents the development at all immature flea stages including eggs, larvae, and pupae. Tested with up to five times the recommended dose, Vectra(R) showed no significant adverse effects.

The unique, elongated, patented applicator tip makes Vectra for Dogs & Puppies(TM) easy to apply to a dog's skin through the hair coat. The rounded tip minimizes risk of skin abrasions. The easy-to-open applicator eliminates splash back and spilling, and the contoured shape makes it easier to handle and apply. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast and efficient, and at the same time, minimizing the potential of a choking hazard.

Summit VetPharm's Bloodhound(R) Technology -- an innovative, proprietary track and trace system, ensures veterinary exclusivity and authenticity of the product. Each package of Vectra(R) can be traced from the point of manufacture to the veterinary purchase. Bloodhound(R) Technology allows Summit VetPharm to maintain the integrity of its products through a secure distribution channel, as well as, guarding against counterfeits. "We are able to enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound(R) Technology, we can help keep companion animal health in the hands of professionals," states Stephanus.

Vectra for Dogs & Puppies(TM), Vectra(R) for Cats & Kittens, Vectra for Cats(R) and Vectra 3D(R) are available to veterinarians through Summit VetPharm and Abbott Animal Health sales representatives, as well as from the following distributors: Henry Schein Animal Health, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., NLS Animal Health, PCI Animal Health, Sanum Puerto Rico, Victor Medical Company and Webster Veterinary.

Summit VetPharm

Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. Based in Fort Lee, New Jersey, Summit VetPharm is a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies. For more information, visit Summit VetPharm at www.summitvetpharm.com.


'/>"/>
SOURCE Summit VetPharm
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. Education Key Focus of Michigan Policy Summit
4. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
5. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
6. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
7. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
8. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
9. Summit on Spinal Muscular Atrophy
10. Global Leaders Converge for Special Olympics Global Policy Summit
11. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: